These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31051391)

  • 1. The long-term economic effects of polio: Evidence from the introduction of the polio vaccine to Sweden in 1957.
    Serratos-Sotelo L; Bengtsson T; Nilsson A
    Econ Hum Biol; 2019 Dec; 35():32-41. PubMed ID: 31051391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Were there long-term economic effects of exposure to polio vaccination? An analysis of migrants to Sweden 1946-2003.
    Serratos-Sotelo L
    SSM Popul Health; 2020 Aug; 11():100589. PubMed ID: 32577493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge of mothers on poliomyelitis and other vaccine preventable diseases and vaccination status of children in pastoralist and semi-pastoralist areas of Ethiopia.
    Dinku B; Bisrat F; Kebede Y; Asegidew B; Fantahun M
    Ethiop Med J; 2013 Jul; 51 Suppl 1():59-66. PubMed ID: 24380208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polio eradication in India: some observations.
    Paul Y; Priya
    Vaccine; 2004 Oct; 22(31-32):4144-8. PubMed ID: 15532129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polio supplementary immunization activities and equity in access to vaccination: evidence from the demographic and health surveys.
    Helleringer S; Abdelwahab J; Vandenent M
    J Infect Dis; 2014 Nov; 210 Suppl 1():S531-9. PubMed ID: 25316877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term socio-economic consequences and health care costs of poliomyelitis: a historical cohort study involving 3606 polio patients.
    Nielsen NM; Kay L; Wanscher B; Ibsen R; Kjellberg J; Jennum P
    J Neurol; 2016 Jun; 263(6):1120-8. PubMed ID: 27083562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
    Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
    Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The history of polio in Sweden - from infantile paralysis to polio vaccine].
    Axelsson P
    Sven Med Tidskr; 2004; 8(1):57-66. PubMed ID: 16025605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [POLIOMYELITIS ERADICATION--ONE STEP TO ACHIEVE THE GOAL].
    Ljubin-Sternak S; Kaić B; Vilibić-Čavlek T; Mlinarić-Galinović G
    Acta Med Croatica; 2014 Dec; 68(4-5):327-35. PubMed ID: 26285465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.
    Duintjer Tebbens RJ; Thompson KM
    Future Microbiol; 2016 Dec; 11():1549-1561. PubMed ID: 27831742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Taylor S; Khan M; Muhammad A; Akpala O; van Strien M; Morry C; Feek W; Ogden E
    Vaccine; 2017 Nov; 35(47):6438-6443. PubMed ID: 29031691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau.
    Aaby P; Hedegaard K; Sodemann M; Nhante E; Veirum JE; Jakobsen M; Lisse I; Jensen H; Sandström A
    Vaccine; 2005 Feb; 23(14):1746-51. PubMed ID: 15705481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
    Olin P; Giesecke J
    Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria.
    Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M
    J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing resistance to polio immunisation with free health camps and Bluetooth messaging: An update from Kaduna, Northern, Nigeria.
    Birukila G; Babale SM; Epstein H; Gugong V; Anger R; Corkum M; Jehoshaphat Nebanat A; Musoke F; Alabi O
    Glob Public Health; 2017 Jan; 12(1):19-30. PubMed ID: 26998877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.